INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC
Position in NVAX — Novavax Inc
CIK 1818604
ORLANDO, FL
Position in NVAX
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$942
+$128 QoQ
Shares Held
100
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#232
of 263 holders
Holding Since
Dec 2020
7 quarters on record
Common Shares in NVAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC holds $2,775,775 across 54 Biotechnology names. NVAX ranks #39 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,001 | $624,163 | |
| 2 | OMER |
Omeros Corp
|
40,400 | $384,204 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
6,825 | $241,536 | |
| 4 | VKTX |
Viking Therapeutics, Inc.
|
6,057 | $236,283 | |
| 5 | ONCY |
Oncolytics Biotech Inc
|
201,260 | $191,197 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
326 | $161,933 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
1,667 | $130,476 | |
| 8 | EDIT |
Editas Medicine, Inc.
|
31,207 | $101,110 |
All Filings in NVAX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $942 | 100 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $814 | 100 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $672 | 100 | Shares | Sole | 2026-02-03 | |
| 2024-09-30 | $100 | 1,263 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $1,266 | 100 | Shares | Sole | 2024-07-30 | |
| 2021-03-31 | $1,813 | 10 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $1,115 | 10 | Shares | Sole | 2021-04-19 | |
| No filing history on record for this holder in this stock. | ||||||